Clover Health Investments (NASDAQ:CLOV) Stock Price Down 4.5%

Clover Health Investments, Corp. (NASDAQ:CLOV) fell 4.5% during mid-day trading on Thursday . The stock traded as low as $1.05 and last traded at $1.05. 1,316,279 shares changed hands during mid-day trading, a decline of 84% from the average session volume of 8,051,685 shares. The stock had previously closed at $1.10.

Clover Health Investments Trading Up 21.4 %

The firm’s 50 day moving average price is $0.90 and its two-hundred day moving average price is $0.90.

Clover Health Investments (NASDAQ:CLOV) last announced its earnings results on Tuesday, May 7th. The company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.02. Clover Health Investments had a negative net margin of 8.63% and a negative return on equity of 48.07%. The business had revenue of $346.92 million during the quarter, compared to the consensus estimate of $316.10 million. Research analysts expect that Clover Health Investments, Corp. will post -0.21 EPS for the current fiscal year.

Institutional Investors Weigh In On Clover Health Investments

Hedge funds have recently made changes to their positions in the business. Jaffetilchin Investment Partners LLC raised its holdings in Clover Health Investments by 30.2% during the first quarter. Jaffetilchin Investment Partners LLC now owns 49,741 shares of the company’s stock worth $39,000 after purchasing an additional 11,550 shares in the last quarter. Swiss National Bank raised its holdings in Clover Health Investments by 1.6% during the third quarter. Swiss National Bank now owns 782,200 shares of the company’s stock worth $845,000 after purchasing an additional 12,400 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. raised its holdings in Clover Health Investments by 2.6% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 813,695 shares of the company’s stock worth $879,000 after purchasing an additional 20,813 shares in the last quarter. Rathbones Group PLC purchased a new position in Clover Health Investments during the third quarter worth about $27,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Clover Health Investments by 68.9% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 75,444 shares of the company’s stock worth $72,000 after purchasing an additional 30,776 shares in the last quarter. Institutional investors and hedge funds own 19.77% of the company’s stock.

Clover Health Investments Company Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.